Guido Dalbagni
Division of Urology
Memorial Sloan-Kettering Cancer Center
New York
NY 10021
USA
Name/email consistency: high
- Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Dalbagni, G., Vora, K., Kaag, M., Cronin, A., Bochner, B., Donat, S.M., Herr, H.W. Eur. Urol. (2009)
- Can excretory urography detect upper urinary tract tumors after radical cystectomy for urothelial cancer?. Dalbagni, G. Nature Clinical Practice. Urology (2008)
- The management of superficial bladder cancer. Dalbagni, G. Nature Clinical Practice. Urology (2007)
- Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. Dalbagni, G., Russo, P., Bochner, B., Ben-Porat, L., Sheinfeld, J., Sogani, P., Donat, M.S., Herr, H.W., Bajorin, D. J. Clin. Oncol. (2006)
- Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder. Dalbagni, G., Russo, P., Sheinfeld, J., Mazumdar, M., Tong, W., Rabbani, F., Donat, M.S., Herr, H.W., Sogani, P., dePalma, D., Bajorin, D. J. Clin. Oncol. (2002)
- Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study. Dalbagni, G., Ren, Z.P., Herr, H., Cordon-Cardo, C., Reuter, V. Clin. Cancer Res. (2001)
- Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Dalbagni, G., Han, W., Zhang, Z.F., Cordon-Cardo, C., Saigo, P., Fair, W.R., Herr, H., Kim, N., Moore, M.A. Clin. Cancer Res. (1997)